首页 › 基金 › Atom Investors LP › RARE

Atom Investors LP 对 RARE 的持仓历史

ULTRAGENYX PHARMACEUTICAL IN · 医疗保健

Atom Investors LP 在 Q2 2026 的 13F 申报中披露持有 RARE(ULTRAGENYX PHARMACEUTICAL IN)171,771 股,市值约 US$5.7M,约占其申报组合的 0.51%,在其申报持仓中市值排名第 20 位。 Atom Investors LP 最近 2 个申报季度中有 2 个季度披露了 RARE 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)171.77K 股
申报持仓市值$5.74M
组合权重0.51%
首次申报Q1 2026
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Atom Investors LP 对 RARE 的持仓演变

Atom Investors LP 于 Q1 2026 首次披露 RARE 持仓:93,622 股(约 US$2.0M)。 该持仓在 Q2 2026 达到峰值 171,771 股,市值约 US$5.7M。 在 2 次申报中,Atom Investors LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 171,771 股、市值约 US$5.7M,环比增持 78,149 股。。 持仓曾出现大幅变动:Q2 2026 增持约 83% (随后一个季度股价下跌 55%)。

逐季持仓明细

季度股数金额变化
Q1 2026 93.62K $1.96M 新进
Q2 2026 171.77K $5.74M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RARE 与 13F 数据

RARE(ULTRAGENYX PHARMACEUTICAL IN)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 RARE,申报仓位最大的包括:RTW INVESTMENTS, LP (US$260.3M), SANDS CAPITAL MANAGEMENT, LLC (US$105.5M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RARE 的基金

查看 RARE 的全部基金持有人 →

常见问题

How long has Atom Investors LP held RARE?

Atom Investors LP has disclosed RARE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Atom Investors LP's current position in RARE?

As of Q2 2026, Atom Investors LP holds 171.77K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $5.74M, representing 0.51% of its reported portfolio and ranking #20.

Has Atom Investors LP been buying or selling RARE?

In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in RARE. The position peaked in Q2 2026 at 171.77K shares.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, SANDS CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.